Alcohol consumption and alcohol policy

Alcohol consumption and alcohol policy

Alcohol is a unique addictive substance used by many people for different reasons. Alcohol use affects not only the users but also the family and the whole society in a negative way. Alcohol is one of the most commonly used substances for entertainment purposes in the world and 1 in 3 people is a current drinker. 2348 billion people (43% of the population) aged 15 and over are current drinkers and males drink about 2 times more frequently than females (53.6%/32.3%). According to the Global Alcohol and Health Report published by the World Health Organization (WHO) (2018), total alcohol per capita consumption (APC) worldwide aged 15 and over increased from 5.7 liters in 2000 to 6.4 liters in 2016. Harmful alcohol consumption is a major public health problem and it is known to be associated with more than 200 diseases and injuries. Policies and measures to prevent alcohol use are not implemented adequately and the burden of alcohol-related illnesses continues to increase tremendously. In order to prevent and reduce the harmful effects of alcohol, alcohol policies should be formulated based on the best evidence from a public health perspective.

___

  • 1. Kalyoncu A, Mırsal H. Alkol kullanım bozuklukları. Psikiyatri Dünyası 2000;4(1): 22-30 (in Turkish).
  • 2. Akvardarlar Y, Arıkan Z, Berkman K, Dilbaz N, Oral G et al. Madde Bağımlılığı Tanı ve Tedavi Klavuzu El Kitabı. TC Sağlık Bakanlığı Sağlık Hizmetleri Genel Müdürlüğü. Ankara, Turkey: Pozitif Matbaa; 2011 (in Turkish).
  • 3. Erci B. Lise öğrencilerinde madde bağımlılığı ve etkileyen ailesel faktörler. Atatürk Üniversitesi Hemşirelik Yüksekokulu Dergisi 1999;2(1): 83-94 (in Turkish).
  • 4. Ögel K, Tamar D, Evren C, Sır A. Madde kullanımı ve suç. Psikiyatri Psikoloji Psikofarmakoloji (3P) Dergisi Ek sayı 2010 (in Turkish).
  • 5. World Health Organization. Global Status Report on Alcohol and Health 2018. Geneva, Switzerland: WHO; 2018.
  • 6. Collaborators GA. Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet (London, England) 2018;392(10152): 1015-1035.
  • 7. Mercan S, Onaran Öİ, İlbak A, Atasoy H, Teloğlu EŞ et al. Alkol Tüketim Kültürü ve Alkol Araştırmaları ile Alkol Kontrol Politikaları Konusunda Görüşler: Nitel Bir Araştırma. ADDICTA: The Turkish Journal on Addictions 2018;5(3): 473- 505.
  • 8. Turkish Republic Ministry of Health. Health Statistics Year Book-2016. Ankara, Turkey; Ministry of Health, General Directorate of Health Research; 2017.
  • 9. Kendagor A, Gathecha G, Ntakuka MW, Nyakundi P, Gathere S et al. Prevalence and determinants of heavy episodic drinking among adults in Kenya: analysis of the STEPwise survey, 2015. BMC Public Health 2018;18(Suppl 3): 66-73.
  • 10. World Health Organization. Global health risks, mortality and burden of disease attributable to selected major risks. Geneva, Switzerland: WHO; 2009.
  • 11. Collins SE. Associations Between Socioeconomic Factors and Alcohol Outcomes. Alcohol Research 2016;38(1): 83-94.
  • 12. United Nations. Transforming Our World: The 2030 Agenda for Sustainable Development. New York, NY, USA: UN; 2015.
  • 13. Öztürk YE, Kırlıoğlu M, Kıraç R. Alkol ve madde bağımlılığında risk faktörleri. Selçuk Üniversitesi Sosyal Bilimler Meslek Yüksek Okulu Dergisi 2016;18(2): 97-118 (in Turkish).
  • 14. The European School Survey Project on Alcohol and Other Drugs (ESPAD). Results from the European School Survey Project on Alcohol and Other Drugs 2015. Lisbon, Portugal; 2015.
  • 15. World Health Organization. The Global School-Based Student Health Survey GSHS Core Module. Geneva, Switzerland: WHO; 2013.
  • 16. Ilhan MN, Arikan Z, Kotan Z, Tunçoğlu T, Pinarci M et al. Prevalence and socio-demographic determinants of tobacco, alcohol, substance use and drug misuse in general population in Turkey. Noro Psychiatry Archives. 2016;53(3): 205-212.
  • 17. Tot Ş. Mersin Üniversitesi öğrencilerinde sigara ve alkol kullanım yaygınlığı ve ilişkili özellikler. Anatolian Journal of Psychiatry 2002;3: 227-231.
  • 18. Allen L, Williams J, Townsend N, Mikkelsen B, Roberts N et al. Socioeconomic status and non-communicable disease behavioral risk factors in low-income and lower-middleincome countries: a systematic review. Lancet Global Health. 2017;5(3): 277-289.
  • 19. Bellis MA, Hughes K, Nicholls J, Sheron N, Gilmore I et al. The alcohol harm paradox: using a national survey to explore how alcohol may disproportionately impact health in deprived individuals. BMC Public Health 2016;16: 111-120.
  • 20. Stringhini S, Carmeli C, Jokela M, Avendano M, Muennig P et al. Socioeconomic status and the 25 x 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1.7 million men and women. Lancet (London, England) 2017;389(10075): 1229-1237.
  • 21. World Health Organization. Management of substance abuseWHO launches SAFER alcohol control initiative to prevent and reduce alcohol-related death and disability. Geneva, Switzerland: WHO; 2018.
  • 22. World Health Organization. Global Status Report on Alcohol and Health 2011 [online]. Geneva, Switzerland: WHO.
  • 23. World Health Organization. Global Strategy to Reduce the Harmful Use of Alcohol. Geneva, Switzerland: WHO; 2010 [online].
  • 24. Martin T, Solbeck P, Mayers D, Langille R, Buczek Y et al. A Review of Alcohol-Impaired Driving: The Role of Blood Alcohol Concentration and Complexity of the Driving Task. Journal of Forensic Sciences. 2013;58(5): 1238-1250.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Neuropeptide Y1 receptor antagonist but not neuropeptide Y itself increased bone mineral density when locally injected with hyaluronic acid in male Wistar rats

Muhammer Özgür ÇEVİK, Feza KORKUSUZ, Petek KORKUSUZ

Response to letter to the editor: Radiological approaches to COVID-19 pneumonia

Tevfik ÖZLÜ, Şule AKÇAY, Aydın YILMAZ

What is the impact of PPAR-γ agonist-rosiglitazone on ovarian reserve after hysterectomy? An experimental study

Berna DİLBAZ, Betül DÜNDAR, Ümit GÖKTOLGA, Ömer Lütfi TAPISIZ, Burcu GÜNDOĞDU, Kamil Hakan MÜFTÜOĞLU, Serkan Barış MÜLAZIMOĞLU

Development of albumin macroinitiator for polymers to use in DNA origami coating

Ezgi EMÜL, Necdet SAĞLAM, Aykut BİLİR

The association between chronic spontaneous urticaria and HLA class I and class II antigen

Songül ÇİLDAĞ, Taşkın ŞENTÜRK, Neslihan DOĞAN, Çiğdem YENİSEY

Surface enhanced Raman spectroscopy as a novel tool for rapid quantification of heroin and metabolites in saliva

Mahmut Şerif YILDIRIM, Necdet SAĞLAM, Hasan İLHAN, Ramazan AKÇAN, Uğur TAMER, Burcu GÜVEN

Surgical management of insulinomas at the Azerbaijan Medical University: a retrospective study of 21 cases over a 10-year period

Elgun SAMADOV, Rovshan HASANOV, Nuru BAYRAMOV, Aytekin ÜNLÜ, Patrizio PETRONE

The utility of synovial fluid levels of ADAMTS9 and ADAMTS4 in predicting treatment responses to intraarticular steroid injections in patients with knee osteoarthritis

Kenan ÖZLER

Alterations in follicular fluid BMP-15 RNA expression in women undergoing controlled ovarian hyperstimulation

Şükriye Derya DEVECİ

The triglyceride-glucose index predicts peripheral artery disease complexity

Hüseyin AYHAN, Telat KELEŞ, Bilge DURAN KARADUMAN, Engin BOZKURT